{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:41:17Z","timestamp":1791859277121,"version":"4.3.4"},"reference-count":30,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"unspecified","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["K23 AR068441 (Dr. Broder)"],"award-info":[{"award-number":["K23 AR068441 (Dr. Broder)"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["KL2 TR002558 (Dr. Wang)"],"award-info":[{"award-number":["KL2 TR002558 (Dr. Wang)"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006732","name":"New York University","doi-asserted-by":"publisher","award":["NIH\/NCI P30CA016087."],"award-info":[{"award-number":["NIH\/NCI P30CA016087."]}],"id":[{"id":"10.13039\/100006732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Lupus Sci Med"],"accepted":{"date-parts":[[2021,12,23]]},"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Treatment failures for lupus nephritis (LN) are high with 10%\u201330% of patients progressing to end-stage renal disease (ESRD) within 10 years. Interstitial fibrosis\/tubular atrophy (IFTA) is a predictor of progression to ESRD. Prior studies suggest that tubulointerstitial injury secondary to proteinuria in LN is mediated by complement activation in the tubules, specifically through the membrane attack complex (MAC). This study aimed to investigate the associations between tubular MAC deposition with IFTA and proteinuria.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In this cross-sectional study, LN kidney biopsies were assessed for MAC deposition by staining for Complement C9, a component of the MAC. Chromogenic immunohistochemistry was performed on paraffin-embedded human renal biopsy sections using unconjugated, murine anti-human Complement C9 (Hycult Biotech, clone X197). Tubular C9 staining intensity was analysed as present versus absent. IFTA was defined as minimal (&lt;10%), mild (10%\u201324%), moderate (25%\u201350%) and severe (&gt;50%).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Renal biopsies from 30 patients with LN were studied. There were 24 (80%) female sex, mean age (SD) was 33 (12) years old and 23 (77%) had pure\/mixed proliferative LN. Tubular C9 staining was present in 7 (23%) biopsies. 27 patients had minimal-to-mild IFTA and 3 patients had moderate IFTA. Among the C9 + patients, 3 (43%) had moderate IFTA as compared with none in the C9- group, p=0.009. C9 + patients had higher median (IQR) proteinuria as compared with C9- patients: 6.2\u2009g (3.3\u201313.1) vs 2.4\u2009g (1.3\u20134.6), p=0.001 at the time of biopsy. There was no difference in estimated glomerular filtration rate (eGFR) between the C9 + and C9- groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>This study demonstrated that tubular MAC deposition is associated with higher degree of IFTA and proteinuria, which are predictors of progression to ESRD. These results suggest that tubular MAC deposition may be useful in classification of LN. Understanding the role of complement in tubulointerstitial injury will also identify new avenues for LN treatment.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/lupus-2021-000576","type":"journal-article","created":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T11:05:51Z","timestamp":1641553551000},"page":"e000576","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":20,"title":["Membrane attack complex (MAC) deposition in renal tubules is associated with interstitial fibrosis and tubular atrophy: a pilot study"],"prefix":"10.1136","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8725-1974","authenticated-orcid":false,"given":"Shudan","family":"Wang","sequence":"first","affiliation":[{"name":"Rheumatology, Montefiore Medical Center, Bronx, New York, USA"},{"name":"Rheumatology, Albert Einstein College of Medicine, Bronx, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Wu","sequence":"additional","affiliation":[{"name":"Pathology, NYU Langone Health, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2028-6873","authenticated-orcid":false,"given":"Luis","family":"Chiriboga","sequence":"additional","affiliation":[{"name":"Pathology, NYU Langone Health, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1864-4034","authenticated-orcid":false,"given":"Briana","family":"Zeck","sequence":"additional","affiliation":[{"name":"Pathology, NYU Langone Health, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Goilav","sequence":"additional","affiliation":[{"name":"Nephrology, The Children\u2019s Hospital at Montefiore, Bronx, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwei","family":"Wang","sequence":"additional","affiliation":[{"name":"Rheumatology, Morristown Medical Center, Morristown, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra Londono","family":"Jimenez","sequence":"additional","affiliation":[{"name":"Rheumatology, Montefiore Medical Center, Bronx, New York, USA"},{"name":"Rheumatology, Albert Einstein College of Medicine, Bronx, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3204-6068","authenticated-orcid":false,"given":"Chaim","family":"Putterman","sequence":"additional","affiliation":[{"name":"Rheumatology, Albert Einstein College of Medicine, Bronx, New York, USA"},{"name":"Bar-Ilan University, Ramat Gan, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Pathology, Montefiore Medical Center, Bronx, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2677-945X","authenticated-orcid":false,"given":"James","family":"Pullman","sequence":"additional","affiliation":[{"name":"Pathology, Montefiore Medical Center, Bronx, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4772-3057","authenticated-orcid":false,"given":"Anna","family":"Broder","sequence":"additional","affiliation":[{"name":"Rheumatology, Montefiore Medical Center, Bronx, New York, USA"},{"name":"Rheumatology, Albert Einstein College of Medicine, Bronx, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H Michael","family":"Belmont","sequence":"additional","affiliation":[{"name":"Rheumatology, NYU Langone Health, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,1,7]]},"reference":[{"key":"2025091512515762000_9.1.e000576.1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38006"},{"key":"2025091512515762000_9.1.e000576.2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.kint.2016.03.042","article-title":"Insights into the epidemiology and management\u00a0of\u00a0lupus nephritis from the\u00a0US\u00a0rheumatologist's perspective","volume":"90","author":"Hoover","year":"2016","journal-title":"Kidney Int"},{"key":"2025091512515762000_9.1.e000576.3","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2008101028"},{"key":"2025091512515762000_9.1.e000576.4","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013010026"},{"key":"2025091512515762000_9.1.e000576.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.11.023"},{"key":"2025091512515762000_9.1.e000576.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2017.07.007"},{"key":"2025091512515762000_9.1.e000576.7","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1002\/art.40575","article-title":"Brief report: tubulointerstitial damage in lupus nephritis: a comparison of the factors associated with tubulointerstitial inflammation and renal scarring","volume":"70","author":"Londo\u00f1o Jimenez","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"2025091512515762000_9.1.e000576.8","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20441"},{"key":"2025091512515762000_9.1.e000576.9","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000070032.58017.20"},{"key":"2025091512515762000_9.1.e000576.10","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V134928"},{"key":"2025091512515762000_9.1.e000576.11","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V10112323"},{"key":"2025091512515762000_9.1.e000576.12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.67106.x"},{"key":"2025091512515762000_9.1.e000576.13","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200315645"},{"key":"2025091512515762000_9.1.e000576.14","doi-asserted-by":"crossref","first-page":"380","DOI":"10.4049\/jimmunol.127.1.380","article-title":"The membrane attack mechanism of complement: photolabeling reveals insertion of terminal proteins into target membrane","volume":"127","author":"Hu","year":"1981","journal-title":"J Immunol"},{"key":"2025091512515762000_9.1.e000576.15","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/91.2.144"},{"key":"2025091512515762000_9.1.e000576.16","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1986.198"},{"key":"2025091512515762000_9.1.e000576.17","doi-asserted-by":"publisher","DOI":"10.1084\/jem.154.6.1779"},{"key":"2025091512515762000_9.1.e000576.18","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.kint.2018.09.027","article-title":"Glomerular membrane attack complex is not a reliable marker of ongoing C5 activation in lupus nephritis","volume":"95","author":"Wilson","year":"2019","journal-title":"Kidney Int"},{"key":"2025091512515762000_9.1.e000576.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2019.07.030"},{"key":"2025091512515762000_9.1.e000576.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2013.02.014"},{"key":"2025091512515762000_9.1.e000576.21","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.semarthrit.2018.01.004","article-title":"Membrane attack complex (MAC) deposition in lupus nephritis is associated with hypertension and poor clinical response to treatment","volume":"48","author":"Wang","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"2025091512515762000_9.1.e000576.22","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/0161-5890(92)90129-L","article-title":"Analysis of C5b-8 binding sites in the C9 molecule using monoclonal antibodies: participation of two separate epitopes of C9 in C5b-8 binding","volume":"29","author":"Hatanaka","year":"1992","journal-title":"Mol Immunol"},{"key":"2025091512515762000_9.1.e000576.23","doi-asserted-by":"publisher","DOI":"10.1177\/0961203310371154"},{"key":"2025091512515762000_9.1.e000576.24","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J Rheumatol"},{"key":"2025091512515762000_9.1.e000576.25","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-145-4-200608150-00004"},{"key":"2025091512515762000_9.1.e000576.26","first-page":"315","article-title":"Role of ammonia in tubulointerstitial injury","volume":"16","author":"Clark","year":"1990","journal-title":"Miner Electrolyte Metab"},{"key":"2025091512515762000_9.1.e000576.27","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112020"},{"key":"2025091512515762000_9.1.e000576.28","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10587"},{"key":"2025091512515762000_9.1.e000576.29","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1093\/ndt\/10.7.1166","article-title":"The pathogenetic significance of C5b-9 in IgA nephropathy","volume":"10","author":"Alexopoulos","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"2025091512515762000_9.1.e000576.30","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cca.2018.03.033","article-title":"Lectin-Induced renal local complement activation is involved in tubular interstitial injury in diabetic nephropathy","volume":"482","author":"Zheng","year":"2018","journal-title":"Clin Chim Acta"}],"container-title":["Lupus Science &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/lupus-2021-000576","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T19:52:06Z","timestamp":1757965926000},"score":1,"resource":{"primary":{"URL":"https:\/\/lupus.bmj.com\/lookup\/doi\/10.1136\/lupus-2021-000576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1,7]]},"published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1136\/lupus-2021-000576"],"URL":"https:\/\/doi.org\/10.1136\/lupus-2021-000576","relation":{},"ISSN":["2053-8790"],"issn-type":[{"value":"2053-8790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}